C2i Genomics nets $100m

C2i Genomics, a cancer intelligence company, has raised $100 million in financing.

C2i Genomics, a cancer intelligence company, has raised $100 million in financing. Casdin Capital led the round with participation from other investors that included NFX, Duquesne Family Office, Section 32, iGlobe Partners and Driehaus Capital.

Source: Press Release